169 related articles for article (PubMed ID: 38778133)
1. Cymoxanil disrupts RNA synthesis through inhibiting the activity of dihydrofolate reductase.
Kazmirchuk TDD; Burnside DJ; Wang J; Jagadeesan SK; Al-Gafari M; Silva E; Potter T; Bradbury-Jost C; Ramessur NB; Ellis B; Takallou S; Hajikarimlou M; Moteshareie H; Said KB; Samanfar B; Fletcher E; Golshani A
Sci Rep; 2024 May; 14(1):11695. PubMed ID: 38778133
[TBL] [Abstract][Full Text] [Related]
2. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.
Brophy VH; Vasquez J; Nelson RG; Forney JR; Rosowsky A; Sibley CH
Antimicrob Agents Chemother; 2000 Apr; 44(4):1019-28. PubMed ID: 10722506
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human dihydrofolate reductase activity and expression.
Abali EE; Skacel NE; Celikkaya H; Hsieh YC
Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro.
Chu E; Takimoto CH; Voeller D; Grem JL; Allegra CJ
Biochemistry; 1993 May; 32(18):4756-60. PubMed ID: 8490020
[TBL] [Abstract][Full Text] [Related]
5. Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.
Gerum AB; Ulmer JE; Jacobus DP; Jensen NP; Sherman DR; Sibley CH
Antimicrob Agents Chemother; 2002 Nov; 46(11):3362-9. PubMed ID: 12384337
[TBL] [Abstract][Full Text] [Related]
6. Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.
Ma L; Jia Q; Kovacs JA
Antimicrob Agents Chemother; 2002 Sep; 46(9):3101-3. PubMed ID: 12183283
[TBL] [Abstract][Full Text] [Related]
7. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
8. Potency boost of a
Aragaw WW; Lee BM; Yang X; Zimmerman MD; Gengenbacher M; Dartois V; Chui WK; Jackson CJ; Dick T
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161270
[TBL] [Abstract][Full Text] [Related]
9. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
10. Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives.
Shibasaki S; Sakata K; Ishii J; Kondo A; Ueda M
Appl Microbiol Biotechnol; 2008 Sep; 80(4):735-43. PubMed ID: 18670770
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoinformatic Study on the Selective Inhibition of the Protozoan Dihydrofolate Reductase Enzymes.
Sharma VK; Abbat S; Bharatam PV
Mol Inform; 2017 Nov; 36(11):. PubMed ID: 28605138
[TBL] [Abstract][Full Text] [Related]
12. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
Cortese JF; Plowe CV
Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
[TBL] [Abstract][Full Text] [Related]
13. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
[TBL] [Abstract][Full Text] [Related]
14. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.
Ercikan-Abali EA; Banerjee D; Waltham MC; Skacel N; Scotto KW; Bertino JR
Biochemistry; 1997 Oct; 36(40):12317-22. PubMed ID: 9315871
[TBL] [Abstract][Full Text] [Related]
15. Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.
Wang Y; Bruenn JA; Queener SF; Cody V
Antimicrob Agents Chemother; 2001 Sep; 45(9):2517-23. PubMed ID: 11502523
[TBL] [Abstract][Full Text] [Related]
16. Lausannevirus Encodes a Functional Dihydrofolate Reductase Susceptible to Proguanil.
Mueller L; Hauser PM; Gauye F; Greub G
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137801
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
[TBL] [Abstract][Full Text] [Related]
18. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
[TBL] [Abstract][Full Text] [Related]
19. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
20. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
